Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2013
06/06/2013US20130143870 Novel compounds
06/06/2013US20130143865 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/06/2013US20130143863 New bicyclic dihydroisoquinoline-1-one derivatives
06/06/2013US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use
06/06/2013US20130143860 Guanidine compound
06/06/2013US20130143859 Novel prolylcarboxypeptidase inhibitors
06/06/2013US20130143843 Aryl dihydropyridinone and piperidinone mgat2 inhibitors
06/06/2013US20130142807 Compositions and methods for inhibition of the jak pathway
06/06/2013DE19907945B4 Herstellung von sterisch gehinderten Aminethern Preparation of sterically hindered amine ethers
06/06/2013DE112010005815T5 Bicarbazolverbindungen für OLEDs Bicarbazolverbindungen for OLEDs
06/06/2013CA2857689A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
06/06/2013CA2857441A1 Carboxamide-substituted heteroaryl-pyrazoles and their use
06/06/2013CA2857405A1 Poly (adp-ribose) polymerase inhibitor
06/06/2013CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases
06/06/2013CA2856839A1 Substituted anilines as ccr(4) antagonists
06/06/2013CA2856769A1 Novel 2h-indazoles as ep2 receptor antagonists
06/06/2013CA2856453A1 Insecticidal triazinone derivatives
06/06/2013CA2855001A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
06/06/2013CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives
06/06/2013CA2850644A1 Substituted 4-phenyl-pyridines for the treatment of nk-1 receptor related diseases
06/06/2013CA2850594A1 Aminopyrimidine derivatives as lrrk2 modulators
06/06/2013CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
06/05/2013EP2599778A1 Diamide Compounds having Muscarinic Receptor Antagonist and Beta 2 Adrenergic Receptor Agonist Activity
06/05/2013EP2599776A1 Therapeutic agent for neurological diseases
06/05/2013EP2599774A1 Condensed ring pyridine compound
06/05/2013EP2598499A2 Process for the preparation of imatinib mesylate
06/05/2013EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors
06/05/2013EP2598497A1 Cyclic amine azaheterocyclic carboxamides
06/05/2013EP2598487A1 Novel microbiocidal dioxime ether derivatives
06/05/2013EP2598486A1 Bicyclic acetyl-coa carboxylase inhibitors
06/05/2013EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same
06/05/2013EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
06/05/2013EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors
06/05/2013EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
06/05/2013EP2597955A1 Quinoline derivatives and melk inhibitors containing the same
06/05/2013CN103140486A Co-crystals and salts of ccr3-inhibitors
06/05/2013CN103140485A Crystalline oxalate salts of a diamide compound
06/05/2013CN103140484A Cyclic amine azaheterocyclic carboxamides
06/05/2013CN103140483A New heterocyclic compounds as pesticides
06/05/2013CN103140480A Heterocyclic compounds, their preparation and their therapeutic application
06/05/2013CN103140479A Manufacturing process for pyrimidine derivatives
06/05/2013CN103140478A Process for the synthesis of substituted urea compounds
06/05/2013CN103130796A 3-tertiary butyl pyrazole amides compounds and application thereof
06/05/2013CN103130773A N'-pyridyl methylene acethydrazide and preparation method and application thereof
06/05/2013CN103130772A Novel preparation method for chirality sulfoxide type compound and salt of chirality sulfoxide type compound and crystal form
06/05/2013CN103130771A 6-substituted phenyl quinazoline ketone compound and application thereof
06/05/2013CN103130770A 3,5-dihalogenation sulfo-benzamide insecticide
06/05/2013CN103130769A 3-difluoro ethoxy-pyrazole amides compounds and application thereof
06/05/2013CN103130730A Novel quinazoline derivative, and preparation method, anti-HIV activity and anti-TMV activity thereof
06/05/2013CN103130723A Poly (aenosine diphosphate glucose pyrophospheralase (ADP)-ribose) polymerase inhibitor
06/05/2013CN103130722A Novel pyridazine derivative, and preparation method, anti-HIV activity and anti-TMV activity thereof
06/05/2013CN103130710A Anti-enterovirus 71 (EV 71) caprolactam aldehyde compound and preparation method and purpose thereof
06/05/2013CN102311425B Anticoccidiosis compound and preparation method as well as application thereof
06/05/2013CN102219777B Method for preparing sodium rabeprazole
06/05/2013CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof
06/05/2013CN101967139B Fluoro methoxylpyrazole-containing o-formylaminobenzamide compound, synthesis method and application thereof
06/05/2013CN101928278B (S)-4-[(4-chlorphenyl)(pyridine-2-yl)methoxyl]piperidinehydroxyphenpropionate and application thereof
06/05/2013CN101918391B Some 2-pyrazinone derivatives and their use in preparing inhibitors of neutrophile elastase
06/05/2013CN101906096B 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
06/05/2013CN101842361B Pyrazinone derivatives and their use in the treatment of lung diseases
06/05/2013CN101679363B Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
06/05/2013CN101654416B N-[3-nitro-4-methyl-phenyl]-4-aldehyde group-benzamide and preparation method thereof as well as preparation method of derivatives thereof
06/05/2013CN101619043B Quinazoline derivant and medical application thereof
06/05/2013CN101597280B Compound used as seven-pass transmembrane protein and based on sag structure
06/05/2013CN101553480B Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
06/04/2013US8455866 Heterocyclic compound and organic light-emitting device including the same
06/04/2013US8455662 Formulations for benzimidazolyl pyridyl ethers
06/04/2013US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
06/04/2013US8455651 Nicotinic acid and picolinic acid derived near-infrared fluorophores
06/04/2013US8455650 Benzimidazole derivative
06/04/2013US8455649 Insecticidal substituted azinyl derivatives
06/04/2013US8455647 6-aminoisoquinoline compounds
06/04/2013US8455638 Soluble guanylate cyclase activators
06/04/2013US8455521 Diaminoalkane aspartic protease inhibitors
06/04/2013US8455520 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
06/04/2013US8455514 6-and 7-amino isoquinoline compounds and methods for making and using the same
06/04/2013US8455501 N-(5-cycloalkyl)-pyridin-3-yl carboxamides
06/04/2013US8455498 Inhibitors of histone deacetylase
06/04/2013US8455486 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
06/04/2013US8455485 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
06/04/2013US8455482 Substituted pyrrolidine derivative
06/04/2013US8455477 Therapeutic compounds
06/04/2013US8455476 Azetidinyl diamides as monoacylglycerol lipase inhibitors
06/04/2013US8455398 Amide compounds, preparation methods and uses thereof
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
06/04/2013CA2542609C Novel indazole derivatives
06/04/2013CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
05/2013
05/30/2013WO2013078295A2 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/30/2013WO2013076315A2 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
05/30/2013WO2013076225A1 Process for the preparation of gamma amino acids and intermediates used in said process
05/30/2013WO2013076179A1 Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
05/30/2013WO2013076178A1 Crystalline salts of r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
05/30/2013WO2013076177A1 Salt of (r)-3-(6-amino-pyridin-3-yl)-2-(1-cyclohexyl-1h-imidazol-4-yl) ethyl propionate
05/30/2013WO2013076092A1 Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
05/30/2013WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
05/30/2013WO2013075732A1 Process for making crystalline form i of etoricoxib
05/30/2013WO2013075645A1 6-substituted phenyl quinazolone compound and use thereof
05/30/2013WO2013075287A1 Binuclear anthracene pyridine sulphonic acid compound containing flexible chain or salt thereof and preparation process and use thereof
05/30/2013WO2013075286A1 Binuclear anthracene pyridine sulphonic acid compound or salt thereof and preparation process and use thereof
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 1080